Version history

4 versions on record. Newest first; the live version sits at the top with a live indicator.

  1. Live 3c126209345c
    4/12/2026, 3:00:00 PM
    Content snapshot
    {
      "content_md": "# FEN1 Protein\n\n<div class=\"infobox infobox-protein\">\n| | |\n|---|---|\n| **Protein Name** | FEN1 Protein |\n| **Gene** | [FEN1](/genes/fen1) |\n| **UniProt ID** | [P39748](https://www.uniprot.org/uniprot/P39748) |\n| **Alternative Names** | Flap Endonuclease 1, MF1, RAD2 |\n| **Molecular Weight** | ~43 kDa |\n| **Structure** | N-terminal domain, intermediate domain, C-terminal helix-hairpin-helix domain |\n| **Subcellular Localization** | Nucleus |\n</div>\n\n## Overview\n\nFEN1 (Flap Endonuclease 1) is a key DNA repair enzyme essential for DNA replication and repair processes[@liu2000]. As a structure-specific nuclease, FEN1 processes flap structures during DNA replication and repair. Dysregulation of FEN1 has been strongly implicated in neurodegeneration, cancer predisposition, and aging[@mastroeni2018].\n\n## Molecular Function\n\n### DNA Repair Enzymatic Activity\n\nFEN1 possesses multiple enzymatic functions essential for genome stability:\n\n- **Flap endonuclease activity**: Cleaves flap structures that form during DNA replication\n- **5' exonuclease activity**: Removes RNA-DNA primers during Okazaki fragment processing\n- **3' exonuclease activity**: Provides proofreading capability\n\n### Structure-Function Relationship\n\nFEN1's catalytic activities are mediated by conserved domains:\n- **N-terminal domain**: Contains the active site for nuclease activity\n- **Intermediate domain**: Involved in substrate binding\n- **C-terminal helix-hairpin-helix (HhH) domain**: Coordinates metal ions for catalysis\n\n## Role in Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nFEN1 dysfunction significantly contributes to Alzheimer's disease pathogenesis:\n\n1. **DNA Damage Accumulation**: Impaired FEN1 activity leads to accumulation of DNA damage in [neurons](/entities/neurons), accelerating neurodegeneration[@mastroeni2018]. Neurons are particularly vulnerable due to their post-mitotic state.\n\n2. **Genomic Instability**: FEN1 deficiency promotes chromosomal instability that may contribute to [tau](/proteins/tau) pathology and neuronal dysfunction.\n\n3. **Cell Cycle Re-entry**: DNA damage signaling due to FEN1 dysfunction can trigger inappropriate cell cycle re-entry in neurons, leading to [apoptosis](/entities/apoptosis).\n\n4. **Mitochondrial Dysfunction**: FEN1 mutations affect mitochondrial DNA repair, compounding mitochondrial dysfunction in AD.\n\n### Parkinson's Disease\n\nIn Parkinson's disease, FEN1 plays a protective role:\n\n1. **Dopaminergic Neuron Survival**: FEN1 activity is crucial for maintaining genomic integrity in dopaminergic neurons, which are particularly vulnerable to oxidative stress.\n\n2. **[α-Synuclein](/proteins/alpha-synuclein) Interactions**: DNA damage can promote α-synuclein aggregation, and FEN1 dysfunction may accelerate this process[@wong2019].\n\n3. **Mitochondrial DNA Repair**: FEN1 deficiency in mitochondria promotes accumulation of mitochondrial DNA mutations in dopaminergic neurons.\n\n### Amyotrophic Lateral Sclerosis\n\nFEN1 involvement in ALS includes:\n\n1. **Motor Neuron Vulnerability**: FEN1 dysfunction exacerbates DNA damage accumulation in motor neurons.\n\n2. **Oxidative Stress**: The high metabolic demand of motor neurons makes them particularly sensitive to FEN1 deficiency under oxidative stress conditions.\n\n3. **RNA Processing**: FEN1's role in processing R-loops may affect RNA metabolism relevant to [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology.\n\n## DNA Damage Response in Neurodegeneration\n\nFEN1 sits at the nexus of DNA damage response and neurodegeneration:\n\n1. **DNA Damage Signaling**: FEN1 deficiency activates DNA damage response pathways including p53, ATM/ATR\n2. **Apoptosis**: Persistent DNA damage triggers neuronal apoptosis through multiple pathways\n3. **Cellular Senescence**: FEN1 dysfunction can promote cellular senescence in supporting glial cells\n\n## Cancer Predisposition\n\nFEN1 mutations cause cancer predisposition syndromes:\n\n1. **FEN1 Mutations**: Certain FEN1 variants increase cancer risk, particularly breast and ovarian cancer\n2. **Genome Instability**: FEN1 deficiency promotes mutagenic DNA repair\n3. **Therapeutic Implications**: FEN1-targeting therapies show promise in cancer treatment\n\n## Therapeutic Targeting\n\nFEN1-based therapeutic strategies include:\n\n1. **DNA Repair Enhancement**: Developing FEN1 activators to enhance DNA repair in neurons\n2. **Synthetic Lethality**: Exploiting FEN1 deficiency in cancer therapy\n3. **Neuroprotection**: Small molecules that compensate for FEN1 dysfunction\n\n## Research Directions\n\nKey research areas include:\n- Understanding FEN1 regulation in post-mitotic neurons\n- Developing FEN1 activity modulators\n- Biomarker development for DNA repair deficiency\n- Clinical translation of neuroprotective strategies\n\n## See Also\n\n- [FEN1 Gene](/genes/en1)\n- [DNA Repair Pathways](/mechanisms/dna-repair-pathways)\n- [Oxidative Stress Response](/brain-regions/pons)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)\n\n## External Links\n\n- [UniProt: P39748](https://www.uniprot.org/uniprot/P39748)\n- [PDB: FEN1 Structure](https://www.rcsb.org/structure/1UL7)\n- [GeneCards: FEN1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FEN1)\n\n## References\n\n1. [Liu Y, et al., Human FEN1: structure, function, and application in DNA repair. Gene. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10817793/)\n2. [Mastroeni D, et al., DNA damage in Alzheimer's disease and neurodegeneration. Journal of Alzheimer's Disease. 2018 (2018)](https://pubmed.ncbi.nlm.nih.gov/29562546/)\n3. [Wong A, et al., Alpha-synuclein and DNA damage: a vicious cycle in Parkinson's disease. Brain Research. 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30690185/)\n4. [Unknown, Caldecott KW. DNA single-strand break repair and neurodegeneration. DNA Repair. 2004 (2004)](https://pubmed.ncbi.nlm.nih.gov/15317851/)",
      "entity_type": "protein",
      "kg_node_id": "FEN1_PROTEIN",
      "frontmatter_json": {
        "_raw": "python_dict"
      },
      "refs_json": {
        "liu2000": {
          "pmid": "10817793",
          "year": 2000,
          "title": "Human FEN1: structure, function, and application in DNA repair. Gene. 2000",
          "authors": "Liu Y, et al."
        },
        "wong2019": {
          "pmid": "30690185",
          "year": 2019,
          "title": "Alpha-synuclein and DNA damage: a vicious cycle in Parkinson's disease. Brain Research. 2019",
          "authors": "Wong A, et al."
        },
        "caldecott2004": {
          "pmid": "15317851",
          "year": 2004,
          "title": "Caldecott KW. DNA single-strand break repair and neurodegeneration. DNA Repair. 2004"
        },
        "mastroeni2018": {
          "pmid": "29562546",
          "year": 2018,
          "title": "DNA damage in Alzheimer's disease and neurodegeneration. Journal of Alzheimer's Disease. 2018",
          "authors": "Mastroeni D, et al."
        }
      },
      "epistemic_status": "provisional",
      "word_count": 687,
      "source_repo": "NeuroWiki"
    }
  2. v3
    Content snapshot
    {
      "content_md": "# FEN1 Protein\n\n<div class=\"infobox infobox-protein\">\n| | |\n|---|---|\n| **Protein Name** | FEN1 Protein |\n| **Gene** | [FEN1](/genes/fen1) |\n| **UniProt ID** | [P39748](https://www.uniprot.org/uniprot/P39748) |\n| **Alternative Names** | Flap Endonuclease 1, MF1, RAD2 |\n| **Molecular Weight** | ~43 kDa |\n| **Structure** | N-terminal domain, intermediate domain, C-terminal helix-hairpin-helix domain |\n| **Subcellular Localization** | Nucleus |\n</div>\n\n## Overview\n\n\n```mermaid\nflowchart TD\n    FEN1_PROTEIN[\"FEN1_PROTEIN\"]\n    FEN1_PROTEIN_1[\"class\"]\n    FEN1_PROTEIN -->|\"related to\"| FEN1_PROTEIN_1\n    style FEN1_PROTEIN_1 fill:#81c784,stroke:#333,color:#000\n    FEN1_PROTEIN_2[\"infobox\"]\n    FEN1_PROTEIN -->|\"related to\"| FEN1_PROTEIN_2\n    style FEN1_PROTEIN_2 fill:#81c784,stroke:#333,color:#000\n    FEN1_PROTEIN_3[\"infobox-protein\"]\n    FEN1_PROTEIN -->|\"related to\"| FEN1_PROTEIN_3\n    style FEN1_PROTEIN_3 fill:#81c784,stroke:#333,color:#000\n    style FEN1_PROTEIN fill:#4fc3f7,stroke:#333,color:#000\n```\n\nFEN1 (Flap Endonuclease 1) is a key DNA repair enzyme essential for DNA replication and repair processes[@liu2000]. As a structure-specific nuclease, FEN1 processes flap structures during DNA replication and repair. Dysregulation of FEN1 has been strongly implicated in neurodegeneration, cancer predisposition, and aging[@mastroeni2018].\n\n## Molecular Function\n\n### DNA Repair Enzymatic Activity\n\nFEN1 possesses multiple enzymatic functions essential for genome stability:\n\n- **Flap endonuclease activity**: Cleaves flap structures that form during DNA replication\n- **5' exonuclease activity**: Removes RNA-DNA primers during Okazaki fragment processing\n- **3' exonuclease activity**: Provides proofreading capability\n\n### Structure-Function Relationship\n\nFEN1's catalytic activities are mediated by conserved domains:\n- **N-terminal domain**: Contains the active site for nuclease activity\n- **Intermediate domain**: Involved in substrate binding\n- **C-terminal helix-hairpin-helix (HhH) domain**: Coordinates metal ions for catalysis\n\n## Role in Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nFEN1 dysfunction significantly contributes to Alzheimer's disease pathogenesis:\n\n1. **DNA Damage Accumulation**: Impaired FEN1 activity leads to accumulation of DNA damage in [neurons](/entities/neurons), accelerating neurodegeneration[@mastroeni2018]. Neurons are particularly vulnerable due to their post-mitotic state.\n\n2. **Genomic Instability**: FEN1 deficiency promotes chromosomal instability that may contribute to [tau](/proteins/tau) pathology and neuronal dysfunction.\n\n3. **Cell Cycle Re-entry**: DNA damage signaling due to FEN1 dysfunction can trigger inappropriate cell cycle re-entry in neurons, leading to [apoptosis](/entities/apoptosis).\n\n4. **Mitochondrial Dysfunction**: FEN1 mutations affect mitochondrial DNA repair, compounding mitochondrial dysfunction in AD.\n\n### Parkinson's Disease\n\nIn Parkinson's disease, FEN1 plays a protective role:\n\n1. **Dopaminergic Neuron Survival**: FEN1 activity is crucial for maintaining genomic integrity in dopaminergic neurons, which are particularly vulnerable to oxidative stress.\n\n2. **[α-Synuclein](/proteins/alpha-synuclein) Interactions**: DNA damage can promote α-synuclein aggregation, and FEN1 dysfunction may accelerate this process[@wong2019].\n\n3. **Mitochondrial DNA Repair**: FEN1 deficiency in mitochondria promotes accumulation of mitochondrial DNA mutations in dopaminergic neurons.\n\n### Amyotrophic Lateral Sclerosis\n\nFEN1 involvement in ALS includes:\n\n1. **Motor Neuron Vulnerability**: FEN1 dysfunction exacerbates DNA damage accumulation in motor neurons.\n\n2. **Oxidative Stress**: The high metabolic demand of motor neurons makes them particularly sensitive to FEN1 deficiency under oxidative stress conditions.\n\n3. **RNA Processing**: FEN1's role in processing R-loops may affect RNA metabolism relevant to [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology.\n\n## DNA Damage Response in Neurodegeneration\n\nFEN1 sits at the nexus of DNA damage response and neurodegeneration:\n\n1. **DNA Damage Signaling**: FEN1 deficiency activates DNA damage response pathways including p53, ATM/ATR\n2. **Apoptosis**: Persistent DNA damage triggers neuronal apoptosis through multiple pathways\n3. **Cellular Senescence**: FEN1 dysfunction can promote cellular senescence in supporting glial cells\n\n## Cancer Predisposition\n\nFEN1 mutations cause cancer predisposition syndromes:\n\n1. **FEN1 Mutations**: Certain FEN1 variants increase cancer risk, particularly breast and ovarian cancer\n2. **Genome Instability**: FEN1 deficiency promotes mutagenic DNA repair\n3. **Therapeutic Implications**: FEN1-targeting therapies show promise in cancer treatment\n\n## Therapeutic Targeting\n\nFEN1-based therapeutic strategies include:\n\n1. **DNA Repair Enhancement**: Developing FEN1 activators to enhance DNA repair in neurons\n2. **Synthetic Lethality**: Exploiting FEN1 deficiency in cancer therapy\n3. **Neuroprotection**: Small molecules that compensate for FEN1 dysfunction\n\n## Research Directions\n\nKey research areas include:\n- Understanding FEN1 regulation in post-mitotic neurons\n- Developing FEN1 activity modulators\n- Biomarker development for DNA repair deficiency\n- Clinical translation of neuroprotective strategies\n\n## See Also\n\n- [FEN1 Gene](/genes/en1)\n- [DNA Repair Pathways](/mechanisms/dna-repair-pathways)\n- [Oxidative Stress Response](/brain-regions/pons)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)\n\n## External Links\n\n- [UniProt: P39748](https://www.uniprot.org/uniprot/P39748)\n- [PDB: FEN1 Structure](https://www.rcsb.org/structure/1UL7)\n- [GeneCards: FEN1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FEN1)\n\n## References\n\n1. [Liu Y, et al., Human FEN1: structure, function, and application in DNA repair. Gene. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10817793/)\n2. [Mastroeni D, et al., DNA damage in Alzheimer's disease and neurodegeneration. Journal of Alzheimer's Disease. 2018 (2018)](https://pubmed.ncbi.nlm.nih.gov/29562546/)\n3. [Wong A, et al., Alpha-synuclein and DNA damage: a vicious cycle in Parkinson's disease. Brain Research. 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30690185/)\n4. [Unknown, Caldecott KW. DNA single-strand break repair and neurodegeneration. DNA Repair. 2004 (2004)](https://pubmed.ncbi.nlm.nih.gov/15317851/)",
      "entity_type": "protein"
    }
  3. v2
    Content snapshot
    {
      "content_md": "# FEN1 Protein\n\n<div class=\"infobox infobox-protein\">\n| | |\n|---|---|\n| **Protein Name** | FEN1 Protein |\n| **Gene** | [FEN1](/genes/fen1) |\n| **UniProt ID** | [P39748](https://www.uniprot.org/uniprot/P39748) |\n| **Alternative Names** | Flap Endonuclease 1, MF1, RAD2 |\n| **Molecular Weight** | ~43 kDa |\n| **Structure** | N-terminal domain, intermediate domain, C-terminal helix-hairpin-helix domain |\n| **Subcellular Localization** | Nucleus |\n</div>\n\n## Overview\n\nFEN1 (Flap Endonuclease 1) is a key DNA repair enzyme essential for DNA replication and repair processes[@liu2000]. As a structure-specific nuclease, FEN1 processes flap structures during DNA replication and repair. Dysregulation of FEN1 has been strongly implicated in neurodegeneration, cancer predisposition, and aging[@mastroeni2018].\n\n## Molecular Function\n\n### DNA Repair Enzymatic Activity\n\nFEN1 possesses multiple enzymatic functions essential for genome stability:\n\n- **Flap endonuclease activity**: Cleaves flap structures that form during DNA replication\n- **5' exonuclease activity**: Removes RNA-DNA primers during Okazaki fragment processing\n- **3' exonuclease activity**: Provides proofreading capability\n\n### Structure-Function Relationship\n\nFEN1's catalytic activities are mediated by conserved domains:\n- **N-terminal domain**: Contains the active site for nuclease activity\n- **Intermediate domain**: Involved in substrate binding\n- **C-terminal helix-hairpin-helix (HhH) domain**: Coordinates metal ions for catalysis\n\n## Role in Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nFEN1 dysfunction significantly contributes to Alzheimer's disease pathogenesis:\n\n1. **DNA Damage Accumulation**: Impaired FEN1 activity leads to accumulation of DNA damage in [neurons](/entities/neurons), accelerating neurodegeneration[@mastroeni2018]. Neurons are particularly vulnerable due to their post-mitotic state.\n\n2. **Genomic Instability**: FEN1 deficiency promotes chromosomal instability that may contribute to [tau](/proteins/tau) pathology and neuronal dysfunction.\n\n3. **Cell Cycle Re-entry**: DNA damage signaling due to FEN1 dysfunction can trigger inappropriate cell cycle re-entry in neurons, leading to [apoptosis](/entities/apoptosis).\n\n4. **Mitochondrial Dysfunction**: FEN1 mutations affect mitochondrial DNA repair, compounding mitochondrial dysfunction in AD.\n\n### Parkinson's Disease\n\nIn Parkinson's disease, FEN1 plays a protective role:\n\n1. **Dopaminergic Neuron Survival**: FEN1 activity is crucial for maintaining genomic integrity in dopaminergic neurons, which are particularly vulnerable to oxidative stress.\n\n2. **[α-Synuclein](/proteins/alpha-synuclein) Interactions**: DNA damage can promote α-synuclein aggregation, and FEN1 dysfunction may accelerate this process[@wong2019].\n\n3. **Mitochondrial DNA Repair**: FEN1 deficiency in mitochondria promotes accumulation of mitochondrial DNA mutations in dopaminergic neurons.\n\n### Amyotrophic Lateral Sclerosis\n\nFEN1 involvement in ALS includes:\n\n1. **Motor Neuron Vulnerability**: FEN1 dysfunction exacerbates DNA damage accumulation in motor neurons.\n\n2. **Oxidative Stress**: The high metabolic demand of motor neurons makes them particularly sensitive to FEN1 deficiency under oxidative stress conditions.\n\n3. **RNA Processing**: FEN1's role in processing R-loops may affect RNA metabolism relevant to [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology.\n\n## DNA Damage Response in Neurodegeneration\n\nFEN1 sits at the nexus of DNA damage response and neurodegeneration:\n\n1. **DNA Damage Signaling**: FEN1 deficiency activates DNA damage response pathways including p53, ATM/ATR\n2. **Apoptosis**: Persistent DNA damage triggers neuronal apoptosis through multiple pathways\n3. **Cellular Senescence**: FEN1 dysfunction can promote cellular senescence in supporting glial cells\n\n## Cancer Predisposition\n\nFEN1 mutations cause cancer predisposition syndromes:\n\n1. **FEN1 Mutations**: Certain FEN1 variants increase cancer risk, particularly breast and ovarian cancer\n2. **Genome Instability**: FEN1 deficiency promotes mutagenic DNA repair\n3. **Therapeutic Implications**: FEN1-targeting therapies show promise in cancer treatment\n\n## Therapeutic Targeting\n\nFEN1-based therapeutic strategies include:\n\n1. **DNA Repair Enhancement**: Developing FEN1 activators to enhance DNA repair in neurons\n2. **Synthetic Lethality**: Exploiting FEN1 deficiency in cancer therapy\n3. **Neuroprotection**: Small molecules that compensate for FEN1 dysfunction\n\n## Research Directions\n\nKey research areas include:\n- Understanding FEN1 regulation in post-mitotic neurons\n- Developing FEN1 activity modulators\n- Biomarker development for DNA repair deficiency\n- Clinical translation of neuroprotective strategies\n\n## See Also\n\n- [FEN1 Gene](/genes/en1)\n- [DNA Repair Pathways](/mechanisms/dna-repair-pathways)\n- [Oxidative Stress Response](/brain-regions/pons)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)\n\n## External Links\n\n- [UniProt: P39748](https://www.uniprot.org/uniprot/P39748)\n- [PDB: FEN1 Structure](https://www.rcsb.org/structure/1UL7)\n- [GeneCards: FEN1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FEN1)\n\n## References\n\n1. [Liu Y, et al., Human FEN1: structure, function, and application in DNA repair. Gene. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10817793/)\n2. [Mastroeni D, et al., DNA damage in Alzheimer's disease and neurodegeneration. Journal of Alzheimer's Disease. 2018 (2018)](https://pubmed.ncbi.nlm.nih.gov/29562546/)\n3. [Wong A, et al., Alpha-synuclein and DNA damage: a vicious cycle in Parkinson's disease. Brain Research. 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30690185/)\n4. [Unknown, Caldecott KW. DNA single-strand break repair and neurodegeneration. DNA Repair. 2004 (2004)](https://pubmed.ncbi.nlm.nih.gov/15317851/)",
      "entity_type": "protein"
    }
  4. v1
    Content snapshot
    {
      "content_md": "<div class=\"infobox infobox-protein\">\n| | |\n|---|---|\n| **Protein Name** | FEN1 Protein |\n| **Gene** | [FEN1](/genes/fen1) |\n| **UniProt ID** | [P39748](https://www.uniprot.org/uniprot/P39748) |\n| **Alternative Names** | Flap Endonuclease 1, MF1, RAD2 |\n| **Molecular Weight** | ~43 kDa |\n| **Structure** | N-terminal domain, intermediate domain, C-terminal helix-hairpin-helix domain |\n| **Subcellular Localization** | Nucleus |\n</div>\n\n## Overview\n\nFEN1 (Flap Endonuclease 1) is a key DNA repair enzyme essential for DNA replication and repair processes[@liu2000]. As a structure-specific nuclease, FEN1 processes flap structures during DNA replication and repair. Dysregulation of FEN1 has been strongly implicated in neurodegeneration, cancer predisposition, and aging[@mastroeni2018].\n\n## Molecular Function\n\n### DNA Repair Enzymatic Activity\n\nFEN1 possesses multiple enzymatic functions essential for genome stability:\n\n- **Flap endonuclease activity**: Cleaves flap structures that form during DNA replication\n- **5' exonuclease activity**: Removes RNA-DNA primers during Okazaki fragment processing\n- **3' exonuclease activity**: Provides proofreading capability\n\n### Structure-Function Relationship\n\nFEN1's catalytic activities are mediated by conserved domains:\n- **N-terminal domain**: Contains the active site for nuclease activity\n- **Intermediate domain**: Involved in substrate binding\n- **C-terminal helix-hairpin-helix (HhH) domain**: Coordinates metal ions for catalysis\n\n## Role in Neurodegenerative Diseases\n\n### Alzheimer's Disease\n\nFEN1 dysfunction significantly contributes to Alzheimer's disease pathogenesis:\n\n1. **DNA Damage Accumulation**: Impaired FEN1 activity leads to accumulation of DNA damage in [neurons](/entities/neurons), accelerating neurodegeneration[@mastroeni2018]. Neurons are particularly vulnerable due to their post-mitotic state.\n\n2. **Genomic Instability**: FEN1 deficiency promotes chromosomal instability that may contribute to [tau](/proteins/tau) pathology and neuronal dysfunction.\n\n3. **Cell Cycle Re-entry**: DNA damage signaling due to FEN1 dysfunction can trigger inappropriate cell cycle re-entry in neurons, leading to [apoptosis](/entities/apoptosis).\n\n4. **Mitochondrial Dysfunction**: FEN1 mutations affect mitochondrial DNA repair, compounding mitochondrial dysfunction in AD.\n\n### Parkinson's Disease\n\nIn Parkinson's disease, FEN1 plays a protective role:\n\n1. **Dopaminergic Neuron Survival**: FEN1 activity is crucial for maintaining genomic integrity in dopaminergic neurons, which are particularly vulnerable to oxidative stress.\n\n2. **[α-Synuclein](/proteins/alpha-synuclein) Interactions**: DNA damage can promote α-synuclein aggregation, and FEN1 dysfunction may accelerate this process[@wong2019].\n\n3. **Mitochondrial DNA Repair**: FEN1 deficiency in mitochondria promotes accumulation of mitochondrial DNA mutations in dopaminergic neurons.\n\n### Amyotrophic Lateral Sclerosis\n\nFEN1 involvement in ALS includes:\n\n1. **Motor Neuron Vulnerability**: FEN1 dysfunction exacerbates DNA damage accumulation in motor neurons.\n\n2. **Oxidative Stress**: The high metabolic demand of motor neurons makes them particularly sensitive to FEN1 deficiency under oxidative stress conditions.\n\n3. **RNA Processing**: FEN1's role in processing R-loops may affect RNA metabolism relevant to [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology.\n\n## DNA Damage Response in Neurodegeneration\n\nFEN1 sits at the nexus of DNA damage response and neurodegeneration:\n\n1. **DNA Damage Signaling**: FEN1 deficiency activates DNA damage response pathways including p53, ATM/ATR\n2. **Apoptosis**: Persistent DNA damage triggers neuronal apoptosis through multiple pathways\n3. **Cellular Senescence**: FEN1 dysfunction can promote cellular senescence in supporting glial cells\n\n## Cancer Predisposition\n\nFEN1 mutations cause cancer predisposition syndromes:\n\n1. **FEN1 Mutations**: Certain FEN1 variants increase cancer risk, particularly breast and ovarian cancer\n2. **Genome Instability**: FEN1 deficiency promotes mutagenic DNA repair\n3. **Therapeutic Implications**: FEN1-targeting therapies show promise in cancer treatment\n\n## Therapeutic Targeting\n\nFEN1-based therapeutic strategies include:\n\n1. **DNA Repair Enhancement**: Developing FEN1 activators to enhance DNA repair in neurons\n2. **Synthetic Lethality**: Exploiting FEN1 deficiency in cancer therapy\n3. **Neuroprotection**: Small molecules that compensate for FEN1 dysfunction\n\n## Research Directions\n\nKey research areas include:\n- Understanding FEN1 regulation in post-mitotic neurons\n- Developing FEN1 activity modulators\n- Biomarker development for DNA repair deficiency\n- Clinical translation of neuroprotective strategies\n\n## See Also\n\n- [FEN1 Gene](/genes/en1)\n- [DNA Repair Pathways](/mechanisms/dna-repair-pathways)\n- [Oxidative Stress Response](/brain-regions/pons)\n- [Alzheimer's Disease](/diseases/alzheimers-disease)\n- [Parkinson's Disease](/diseases/parkinsons-disease)\n- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)\n\n## External Links\n\n- [UniProt: P39748](https://www.uniprot.org/uniprot/P39748)\n- [PDB: FEN1 Structure](https://www.rcsb.org/structure/1UL7)\n- [GeneCards: FEN1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FEN1)\n\n## References\n\n1. [Liu Y, et al., Human FEN1: structure, function, and application in DNA repair. Gene. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10817793/)\n2. [Mastroeni D, et al., DNA damage in Alzheimer's disease and neurodegeneration. Journal of Alzheimer's Disease. 2018 (2018)](https://pubmed.ncbi.nlm.nih.gov/29562546/)\n3. [Wong A, et al., Alpha-synuclein and DNA damage: a vicious cycle in Parkinson's disease. Brain Research. 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30690185/)\n4. [Unknown, Caldecott KW. DNA single-strand break repair and neurodegeneration. DNA Repair. 2004 (2004)](https://pubmed.ncbi.nlm.nih.gov/15317851/)",
      "entity_type": "protein"
    }